You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY20 is not expected to be complete until September, 2021.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

  1. Novel Circulating RNA-based Markers as Diagnostic Biomarkers of Infectious Diseases

    SBC: CFD Research Corporation            Topic: CBD18A001

    In resource limited settings, rapid and accurate diagnosis of infections is critical for managing potential exposures to highly virulent pathogens,whether occurring from an act of bioterrorism or a natural event. This is especially important for hard to detect intracellular bacterial andalphavirus infections, that overlap symptomatically and often treated empirically due to a lack of reliable and ...

    STTR Phase I 2018 Department of DefenseOffice for Chemical and Biological Defense
  2. Host-Targeted Antiviral Drugs Providing Rapid, Scalable, Stable, Broad-Spectrum MedicalCountermeasure Against Marburg Virus

    SBC: Evrys Bio, LLC            Topic: CBD18A002

    In a pandemic or exposure to weaponized Marburg virus the morbidity, mortality and social unrest that will ensue before vaccines orMilitary operating on foreign soil as well as to the population of the US Homeland. Practically all threat agents of biological origin (except forcertain non-proteinaceous toxins, typically produced by marine organisms and fungi) have their structure and vital function ...

    STTR Phase I 2018 Department of DefenseOffice for Chemical and Biological Defense
  3. Fast Parameter Identification for Personalized Pharmacokinetics

    SBC: Autonomous Healthcare Inc            Topic: DHP17B003

    Drug dosingcan bemademore precise by using pharmacokineticand pharmacodynamicmodeling. Pharmacokinetics is thestudy of the concentration of drugs in tissueasafunction of timeand doseschedule,whereas pharmacodynamics is thestudy of therelationship between drugconcentration and drugeffect. By relating doseto resultant drugconcentration (pharmacokinetics)and concentration to effect (pharmacodynamics) ...

    STTR Phase I 2018 Department of DefenseDefense Health Agency
  4. Hierarchical, Layout-Aware, Radiation Effects Tools Vertically Integrated into an EDA Design Flow for Rad-Hard by Design

    SBC: Reliable MicroSystems, LLC            Topic: DTRA16A003

    The goal of this workis to establish a radiation-aware capability in a commercial EDA design flow that will enable first-pass success in radiation resiliency for DoD ASIC designs in much the same way that existing EDA design suites ensure first pass functionality and performance success of complex ASICs destined for commercial applications.Such an integrated capability does not presently exist.The ...

    STTR Phase II 2018 Department of DefenseDefense Threat Reduction Agency
  5. ECCCHO: Effective Combat Casualty Care Handoff Operations

    SBC: Tier 1 Performance Solutions, LLC            Topic: DHA17B002

    Approximately 70% of sentinel events in medical care are related to communication mishaps, and despite regular and frequent occurrence, an even higher percentage (80%) of severe medical errors are related to miscommunication during handoffs (i.e., the transferring of information, responsibility, and authority for patient care from one provider to another). The TiER1 team proposes to address challe ...

    STTR Phase I 2018 Department of DefenseDefense Health Agency
  6. Infectious Disease Diagnostics and Differentiation of Viral vs. Bacterial Infections for Point ofCare Applications

    SBC: GENECAPTURE            Topic: CBD15C001

    GeneCapture, Inc. is proposing to develop a rapid in vitro diagnostic prototype using our patented molecular-based CAPTURE (ConfirmActive Pathogens Through Unamplified RNA Expression) assay. Based on the results and experience gained in our Phase I STTR contractHDTRA1-16C-0061: Infectious Disease Diagnostics and Differentiation of Viral vs. Bacterial Infections for Point of Care Applications, we p ...

    STTR Phase II 2018 Department of DefenseOffice for Chemical and Biological Defense
  7. Interactive Mixed Media Education augmented Reality Simulation Engine (IMMERSE)

    SBC: CHI Systems, Inc.            Topic: DHA17A003

    CHI Systems, in partnership with the Virginia Serious Games Institute, proposes to design, develop, and assess the Interactive Mixed Media augmented Reality Simulation Engine (IMMERSE) technology, a compelling and instructionally rich training experience using augmented and mixed-reality for TC3 trainees, and then evaluate the impact of the IMMERSE approach on trainee understanding and training ef ...

    STTR Phase I 2017 Department of DefenseDefense Health Agency
  8. VOC Breath Analysis with Ultra-Sensitive Microwave Spectroscopy

    SBC: NOKOMIS, INC            Topic: DHP16C002

    Nokomis proposes to develop a real-time microwave spectroscopy device to identify Volatile Organic Compounds (VOCs) associated with Pulmonary Oxygen Toxicity. Exhaled breath contains VOCs that act as signatures of bodily health, and are able to be utilized for health diagnostics. The proposed work will demonstrate sensitivity to the presence of chemicals at less than 50 ppb concentration levels, a ...

    STTR Phase I 2017 Department of DefenseDefense Health Agency
  9. Ultra-Wide Band RF Quantitative Diagnostics of Burn Injuries

    SBC: NOKOMIS, INC            Topic: DHP16C005

    This proposal is dedicated to development of portable device for -on site- diagnostic of burn injury. The design will utilize a technology Ultra-Wide Band RF waves of ultra-low intensity (harmless by Federal Standards). The emitted RF waves will reflect from boundaries between tissues normal and damaged by injury to quantitatively characterize severity of burn and would require minimal skills fro ...

    STTR Phase I 2017 Department of DefenseDefense Health Agency
  10. Use of Highly Porous Polymer Beads to Remove Anti-A and Anti-B Antibodies from Plasma for Transfusion

    SBC: CytoSorbents Medical Inc.            Topic: DHP15B001

    Plasma from AB donors is considered universal as it can be transfused regardless of recipient blood type and is frequently used to rapidly resuscitate massively bleeding hospital trauma patients and warfighters with combat casualties. However supplies can be rapidly depleted as AB donors make up only 4% of the population. Therefore robust a technology to cost-effectively generate universal plasma ...

    STTR Phase II 2017 Department of DefenseDefense Health Agency
US Flag An Official Website of the United States Government